Tolmar will resume the rights to ELIGARD® in the Canadian Market from Sanofi Canada BUFFALO GROVE, Ill., Oct. 8, 2021 /PRNewswire/ -- Tolmar, a specialty pharmaceutical company, today announced that, ...
Atrix Laboratories Inc. has submitted an Investigational New Drug (IND) application to the Food and Drug Administration to produce its anti-prostate cancer drug, Eligard, in an additional dosage form.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results